48.64

2.42% 1.15

After Hours: 48.50 -0.14 -0.29%

Twist Bioscience Corp (TWST)

Overview News Price History Option Chain Financials Discussions Forecast

Twist Bioscience Corp stock is traded at $48.64, with a volume of 1.93M. It is up +2.42% in the last 24 hours and down -1.90% over the past month. Twist Bioscience Corp is a synthetic biology company that has developed a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's proprietary semiconductor-based manufacturing process synthesizes DNA on silicon rather than traditional plastic plates, enabling the production of high-quality synthetic DNA faster, more affordably, and at scale. This platform overcomes conventional inefficiencies, supports cost-effective, high-throughput synthesis, and allows researchers to accelerate innovation. Geographically, the company operates across the Americas, EMEA, and APAC, deriving the majority of its revenue from the Americas.

Previous Close:

$47.49

Open:

$48.82

24h Volume:

1.93M

Relative Volume:

1.49

Market Cap:

$2.98B

Revenue:

$391.56M

Net Income/Loss:

$-76.58M

P/E Ratio:

-38.16

EPS:

-1.2745

Net Cash Flow:

$-86.72M

1W Performance:

+9.40%

1M Performance:

-1.90%

6M Performance:

+81.83%

1Y Performance:

+9.92%

1-Day Range:

$48.48

$50.82

1-Week Range:

$41.52

$50.82

52-Week Range:

$23.30

$57.88

Twist Bioscience Corp Stock (TWST) Company Profile

Name

Twist Bioscience Corp

Sector

Healthcare (1114)

Industry

Diagnostics & Research (51)

Phone

800-719-0671

Address

681 GATEWAY BLVD., SOUTH SAN FRANCISCO, CA

Employee

979

Twitter

@TwistBioscience

Next Earnings Date

2026-02-02

Latest SEC Filings

TWST's Discussions on Twitter

Compare TWST vs TMO, DHR, IDXX, A, WAT

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
TWST Twist Bioscience Corp	48.64	2.91B	391.56M	-76.58M	-86.72M	-1.2745
TMO Thermo Fisher Scientific Inc	490.77	182.14B	44.56B	6.72B	6.29B	17.74
DHR Danaher Corp	187.15	134.43B	24.57B	3.60B	5.26B	5.051
IDXX Idexx Laboratories Inc	575.72	45.40B	4.30B	1.06B	1.04B	13.08
A Agilent Technologies Inc	112.98	32.27B	7.07B	1.29B	993.00M	4.5355
WAT Waters Corp	302.32	29.62B	3.17B	642.63M	516.49M	10.77

Twist Bioscience Corp Stock (TWST) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Nov-04-25	Initiated	Stephens	Overweight
Dec-13-24	Initiated	Wolfe Research	Outperform
Jun-04-24	Initiated	Guggenheim	Buy
Jan-17-24	Upgrade	Goldman	Neutral → Buy
Sep-27-23	Initiated	Berenberg	Buy
Jan-05-23	Initiated	Scotiabank	Sector Outperform
Jan-03-23	Upgrade	Evercore ISI	In-line → Outperform
Mar-02-22	Resumed	Cowen	Outperform
Oct-15-21	Resumed	Cowen	Outperform
Jun-29-21	Initiated	William Blair	Outperform
Jun-04-21	Initiated	Goldman	Neutral
Apr-12-21	Initiated	Piper Sandler	Overweight
Feb-05-21	Downgrade	JP Morgan	Neutral → Underweight
Jan-04-21	Downgrade	Evercore ISI	Outperform → In-line
Oct-20-20	Initiated	SVB Leerink	Mkt Perform
May-31-19	Initiated	Evercore ISI	Outperform
Nov-26-18	Initiated	JP Morgan	Neutral

View All

Twist Bioscience Corp Stock (TWST) Latest News

Mar 24, 2026

Twist Bioscience Corp. Opens with 5.02% Gain, Outperforming S&P 500's 1.15% Increase - Markets Mojo

Mar 24, 2026

Cathie Wood’s ARK sells Twist Bioscience and buys Circle Internet stock - Investing.com

Mar 24, 2026

Tax-driven share sale by Twist Bioscience (TWST) officer Dennis Cho disclosed - Stock Titan

Mar 24, 2026

Twist Bioscience Corp stock faces scrutiny amid insider selling and biotech sector volatility - AD HOC NEWS

Mar 23, 2026

Published on: 2026-03-23 13:34:03 - baoquankhu1.vn

Mar 23, 2026

Mar 20, 2026

Trading Recap: Can Twist Bioscience Corporation deliver consistent EPS growth2026 Growth vs Value & Accurate Buy Signal Notifications - baoquankhu1.vn

Mar 20, 2026

- Investing.com

Mar 20, 2026

Insider sale notice — TWST (NASDAQ: TWST) 1,742 shares reported - Stock Titan

Mar 20, 2026

TWST (NASDAQ: TWST) files Rule 144 for 354 shares; insider sales detailed - Stock Titan

Mar 20, 2026

Paula Green sells 39,404 TWST shares (NASDAQ: TWST) in Form 144 - Stock Titan

Mar 20, 2026

Twist Bioscience Corp. Experiences Revision in Stock Evaluation Amid Market Dynamics - Markets Mojo

Mar 20, 2026

TWST News | TWIST BIOSCIENCE CORP (NASDAQ:TWST) - ChartMill

Mar 20, 2026

Mar 19, 2026

Robert Chess Sells 10,000 Shares of Twist Bioscience (NASDAQ:TWST) Stock - MarketBeat

Mar 19, 2026

Twist Bioscience director chess sells $470,000 in shares - Investing.com

Mar 19, 2026

Twist Bioscience (TWST) director’s 10b5-1 option exercise and 10K share sale - Stock Titan

Mar 19, 2026

Mar 18, 2026

Twist Bioscience2026 Funding Rounds & List of Investors - Tracxn

Mar 18, 2026

Mar 17, 2026

Fidelity proposes sale of 10,000 TWST shares (TWST) under Form 144 - Stock Titan

Mar 17, 2026

TWST SEC FilingsTwist Bioscience 10-K, 10-Q, 8-K Forms - Stock Titan

Mar 17, 2026

Mar 16, 2026